NYAS Meeting on TB – April 6, 2010

22 Mar 2010
by Working Group

nyas logo

In more than 10 years since the sequence of the Mycobacterium tuberculosis genome was published, the genetic information of the pathogen and genetic tools have shifted the emphasis of TB drug research. This symposium highlights how they are utilized in the quest for novel TB regimens.

This meeting will be presented by the Emerging Infectious Diseases and Microbiology Discussion Group at the New York Academy of Sciences.

Speakers include:

  • Helen Boshoff (NIH)
  • William R. Jacobs, JR. (Albert Einstein college of Medicine)
  • Carl Nathan (Weill Cornell Medical College)
  • Christopher Sassetti (University of Massachusetts Medical School)
  • Dirk Schnappinger (Weill Cornell Medical College)

The meeting is organized by Takushi Kaneko (TB Alliance) and Jennifer Henry (NYAS).

For more information and to register, please visit An online webinar is also available if you are unable to attend in person.

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...